Related Experiment Video
Updated: Jan 20, 2026

A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
The Chiari I malformation
Insights
Chiari I malformation (CIM) understanding has evolved significantly, with modern MRI and surgical interventions now offering effective treatment options for patients previously facing lifelong disability.
Area of Science:
- Neurosurgery
- Neurology
- Medical History
Background:
- Chiari I malformation (CIM) understanding and treatment have historically lagged, with limited discussion in textbooks until recent decades.
- Early management approaches for CIM and associated syringomyelia were largely ineffective, excluding surgical intervention.
Purpose of the Study:
- To review the evolution of Chiari I malformation (CIM) understanding, pathophysiology, and treatment.
- To differentiate symptomatic CIM from asymptomatic tonsillar ectopia.
- To discuss surgical techniques, outcomes, and complications for CIM.
Main Methods:
- Review of historical literature and contemporary neurosurgical practices.
- Analysis of diagnostic advancements, particularly MRI.
- Evaluation of patient selection criteria for surgical intervention.
Main Results:
- Significant advancements in understanding CIM's pathophysiology and natural history over the past 40 years.
- Confirmation of CIM's responsiveness to surgical intervention, leading to improved patient outcomes.
- Emphasis on accurate patient selection based on symptomatology for successful surgical outcomes.
Conclusions:
- Modern neurosurgical approaches have transformed CIM treatment, offering improved quality of life.
- Distinguishing symptomatic CIM from asymptomatic tonsillar ectopia is crucial for appropriate management.
- Continued research is vital for further enhancing patient care for Chiari I malformation.
Abstract:
As with many pathologies, the course of our understanding of the Chiari I malformation (CIM) has developed extensively over time. The early descriptions of the Chiari malformations by Hans Chiari in 1891 opened the door for future classification and research on this topic. However, even over a long timeframe, our understanding of the pathophysiology and, more importantly, treatment, remained in its infancy. As recently as the 1970s, CIM was not discussed in popular neurology textbooks. Syringomyelia is listed as a degenerative disorder with no satisfactory treatment. Radiation therapy was considered an option in treatment, and surgery was thought to play no role. During the last 40 years, equivalent to the duration of a neurosurgical career, our understanding of the pathophysiology and natural history of CIM, coupled with modern MRI, has improved the treatment paradigm for this patient population. More importantly, it has given us evidence confirming that CIM is a disorder responsive to surgical intervention, giving patients once thought to be destined for lifelong disability a comparatively normal life after treatment. The purpose of this article is to offer a review of CIM and its important associated entities. The authors will discuss the evolution in understanding of the Chiari malformation and, importantly, distinguish between symptomatic CIM and asymptomatic tonsillar ectopia, based on imaging and presenting symptomatology. They will discuss techniques for surgical intervention, expected outcomes, and complications after surgery. Proper patient selection for surgery based on appropriate symptomatology is tantamount to achieving good surgical outcomes in this population, separating those who can be helped by surgery from those who are unlikely to improve. While our knowledge of the Chiari malformations continues to improve through the efforts of clinical and basic science researchers, surgeons, and patients, our current understanding of these entities represents a monumental improvement in patient care over a relatively short time period.
More Related Videos
Related Concept Videos
Open Surgical Resection of Cerebral Arteriovenous Malformations
06:51A Patient-Derived Xenograft Model for Venous Malformation
06:59Intrathecal Application of a Fluorescent Dye for the Identification of Cerebrospinal Fluid Leaks in Cochlear Malformation
05:12Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
14:58Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
01:59Cre-LoxP Mediated Induction of Cerebral Cavernous Malformations in a Mouse Model

